647 related articles for article (PubMed ID: 8417962)
21. Expression of the interleukin 6 gene in acute myeloid leukemia and myelodysplastic syndromes: a report on 49 cases.
Collyn d'Hooghe M; Fenaux P; Lantoine D; Loucheux-Lefebvre M; Kerckaert JP
Nouv Rev Fr Hematol (1978); 1990; 32(3):175-7. PubMed ID: 2216700
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia.
Duncombe AS; Heslop HE; Turner M; Meager A; Priest R; Exley T; Brenner MK
J Immunol; 1989 Dec; 143(11):3828-34. PubMed ID: 2584719
[TBL] [Abstract][Full Text] [Related]
23. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
24. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
25. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
26. [Review of relationship between tumor necrosis factor genetic polymorphism and hematological malignancies].
Zhao HY; Chen YX
Ai Zheng; 2003 Feb; 22(2):216-20. PubMed ID: 12600304
[TBL] [Abstract][Full Text] [Related]
27. The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.
Redaelli A; Stephens JM; Laskin BL; Pashos CL; Botteman MF
Expert Rev Anticancer Ther; 2003 Jun; 3(3):311-29. PubMed ID: 12820775
[TBL] [Abstract][Full Text] [Related]
28. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of a novel cytokine and its gene (LD78) expressions in hematopoietic fresh tumor cells and cell lines.
Yamamura Y; Hattori T; Obaru K; Sakai K; Asou N; Takatsuki K; Ohmoto Y; Nomiyama H; Shimada K
J Clin Invest; 1989 Dec; 84(6):1707-12. PubMed ID: 2687328
[TBL] [Abstract][Full Text] [Related]
31. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
[TBL] [Abstract][Full Text] [Related]
32. P53 protein expression in human leukemia and lymphoma cells.
Koníková E; Kusenda J
Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies.
Muñoz L; Nomdedéu JF; López O; Carnicer MJ; Bellido M; Aventín A; Brunet S; Sierra J
Haematologica; 2001 Dec; 86(12):1261-9. PubMed ID: 11726317
[TBL] [Abstract][Full Text] [Related]
35. Frequent aberration of FHIT gene expression in acute leukemias.
Iwai T; Yokota S; Nakao M; Nakazawa N; Taniwaki M; Kimura T; Sonoda Y; Kaneko H; Okuda T; Azuma H; Oka T; Takeda T; Watanabe A; Kikuta A; Asami K; Sekine I; Matsushita T; Tsuchiya T; Mimaya J; Koizumi S; Ohta S; Miyake M; Takaue Y; Iwai A; Fujimoto T
Cancer Res; 1998 Nov; 58(22):5182-7. PubMed ID: 9823330
[TBL] [Abstract][Full Text] [Related]
36. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
37. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
Oka T; Ouchida M; Koyama M; Ogama Y; Takada S; Nakatani Y; Tanaka T; Yoshino T; Hayashi K; Ohara N; Kondo E; Takahashi K; Tsuchiyama J; Tanimoto M; Shimizu K; Akagi T
Cancer Res; 2002 Nov; 62(22):6390-4. PubMed ID: 12438221
[TBL] [Abstract][Full Text] [Related]
38. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
Chai SK; Nichols GL; Rothman P
J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
[TBL] [Abstract][Full Text] [Related]
39. Expression of nuclear envelope lamins A and C in human myeloid leukemias.
Kaufmann SH
Cancer Res; 1992 May; 52(10):2847-53. PubMed ID: 1581898
[TBL] [Abstract][Full Text] [Related]
40. Expression of the Wilms' tumor gene (WT1) in human leukemias.
Miwa H; Beran M; Saunders GF
Leukemia; 1992 May; 6(5):405-9. PubMed ID: 1317488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
